Rayno Life Science Portfolio: Another Buyout- MITI Goes for $1.16B

http://viewtific.com/wp-includes/certificates/pharmacie/rosaced.html M&A Trend Picks Up Steam

http://thebaglab.com/plastic-bags-frosted-die-cut-handle-c-4_6442.html?add_to_wishlist=1429 The beat goes on as Amgen agrees to buy Micromet (MITI $10.95) for $1.16B.Micromet is focused on treatment  of hematologic malignancies with its BiTE monoclonal antibody platform and has four clinical stage  product candidates. The stock was $5 on November 25 ,2011.

cheapest place to buy Maxalt Micromet was added to the Rayno Life Science Portfolio on 2/2/09 at a price of $4.

This is beginning to feel like the biotech market of 1999.

No comments yet.

Leave a Reply